Kumud Kalia - Dec 1, 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Signature
/s/ John G. Saia, as attorney-in-fact for Kumud Kalia
Stock symbol
GH
Transactions as of
Dec 1, 2023
Transactions value $
-$162,249
Form type
4
Date filed
12/4/2023, 06:25 PM
Previous filing
Oct 2, 2023
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +710 +6.25% $0.00 12.1K Dec 1, 2023 Direct
transaction GH COMMON STOCK Tax liability -$9.29K -353 -2.92% $26.33 11.7K Dec 1, 2023 Direct F1
transaction GH COMMON STOCK Sale -$153K -5.8K -49.46% $26.37 5.93K Dec 1, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -710 -12.5% $0.00 4.97K Dec 1, 2023 COMMON STOCK 710 $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $26.395 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F4 Not applicable for Restricted Stock Units.